Literature DB >> 9491999

Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

K Murali-Krishna1, J D Altman, M Suresh, D J Sourdive, A J Zajac, J D Miller, J Slansky, R Ahmed.   

Abstract

Viral infections induce extensive T cell proliferation in vivo, but the specificity of the majority of the responding T cells has not been defined. To address this issue we used tetramers of MHC class I molecules containing viral peptides to directly visualize antigen-specific CD8 T cells during acute LCMV infection of mice. Based on tetramer binding and two sensitive assays measuring interferon-gamma production at the single-cell level, we found that 50%-70% of the activated CD8 T cells were LCMV specific [2 x 10(7) virus-specific cells/spleen]. Following viral clearance, antigen-specific CD8 T cell numbers dropped to 10(6) per spleen and were maintained at this level for the life of the mouse. Upon rechallenge with LCMV, there was rapid expansion of memory T cells, but after infection with the heterologous vaccinia virus there was no detectable change in the numbers of LCMV-specific memory CTL. Therefore, much of the CD8 T cell expansion seen during viral infection represents antigen-specific cells and warrants a revision of our current thinking on the size of the antiviral response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9491999     DOI: 10.1016/s1074-7613(00)80470-7

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  666 in total

1.  An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro.

Authors:  W Rees; J Bender; T K Teague; R M Kedl; F Crawford; P Marrack; J Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Longitudinal phenotypic analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes: correlation with disease progression.

Authors:  G S Ogg; S Kostense; M R Klein; S Jurriaans; D Hamann; A J McMichael; F Miedema
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

Review 3.  Death and destruction of activated T lymphocytes.

Authors:  I N Crispe
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

4.  Gamma interferon expression in CD8(+) T cells is a marker for circulating cytotoxic T lymphocytes that recognize an HLA A2-restricted epitope of human cytomegalovirus phosphoprotein pp65.

Authors:  S A Ghanekar; L E Nomura; M A Suni; L J Picker; H T Maecker; V C Maino
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

5.  Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells.

Authors:  S M Kaech; R Ahmed
Journal:  Nat Immunol       Date:  2001-05       Impact factor: 25.606

6.  In vivo proliferation of naïve and memory influenza-specific CD8(+) T cells.

Authors:  K J Flynn; J M Riberdy; J P Christensen; J D Altman; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

7.  Cytotoxic T-lymphocyte epitopes fused to anthrax toxin induce protective antiviral immunity.

Authors:  A M Doling; J D Ballard; H Shen; K M Krishna; R Ahmed; R J Collier; M N Starnbach
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

8.  The arrival of HLA class II tetramers.

Authors:  A J McMichael; A Kelleher
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

9.  A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge.

Authors:  G T Belz; W Xie; J D Altman; P C Doherty
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 10.  Differences in the regulation of CD4 and CD8 T-cell clones during immune responses.

Authors:  P C Beverley; M K Maini
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-03-29       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.